<DOC>
	<DOCNO>NCT00565136</DOCNO>
	<brief_summary>The study purpose gain experience TOPAS system , minimally- invasively deliver self-fixating mesh treatment pelvic floor weakness woman symptoms moderate fecal incontinence</brief_summary>
	<brief_title>Evaluation Outcomes Restoring Pelvic Floor Support With TOPAS Women With Moderate Fecal Incontinence Symptoms</brief_title>
	<detailed_description>This multi-center study common protocol . Approximately 20-30 patient enrol across 5 site U.S . The study population female least 21 year age attempt satisfied conservative therapy fecal incontinence symptom . The study follow-up two year .</detailed_description>
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>Females least 21 year age evidence pelvic floor weakness Females attempt satisfied conservative therapy dietary change , dietary bulking agent , biofeedback , etc . Subjects , external anal injury , must voluntary sphincter control Subjects unwilling unable sign Informed Consent form Subjects currently pregnant consider future childbearing Subjects contraindicate surgery Subjects allergic polypropylene mesh Subjects enrol concurrent clinical trial Subjects previous implantation mesh trauma pelvic area Subjects engage anal receptive intercourse Subjects significant evacuation disorder chronic constipation Subjects Crohn 's Disease , ulcerative colitis chronic diarrhea primary cause fecal incontinence Subjects hysterectomy within 6 month prior enrollment Subjects vaginal prolapse pass hymen Subjects complete rectal prolapse Subjects history pelvic radiation compromise anal canal Subjects psychiatric disturbance debilitation possible cause fecal incontinence Subjects neurological disorder amyotrophic lateral sclerosis , multiple sclerosis , brain tumor possible cause fecal incontinence symptom Subjects active pelvic infection rectovaginal fistula Subjects negative screen exam colon cancer within 10 year enrollment Subjects inappropriate condition determine physician</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Device study</keyword>
	<keyword>Pelvic floor weakness</keyword>
	<keyword>Fecal incontinence</keyword>
</DOC>